DKSH and DFE Pharma sign exclusive distrib…

DKSH, a leading Market Expansion Services provider, and DFE Pharma, the world’s leading manufacturer of pharmaceutical excipients, have signed an exclusive agreement to market, sell and distribute DFE Pharma’s Pharmacel (pharmaceutical grade) Microcrystalline Cellulose (MCC) in eight European countries.

Zurich, Switzerland, March 4, 2015 – DKSH’s Business Unit Performance Materials, a leading specialty chemicals distributor, has been appointed exclusive Market Expansion Services partner for DFE Pharma’s Pharmacel MCC excipient for France, Switzerland, UK, Ireland, Denmark, Finland, Norway and Sweden.

DFE Pharma is the global leader in excipient solutions and develops, produces and markets excipients for oral solid dose and dry powder inhalation formulations.

DKSH presently partners DFE Pharma in the Philippines, where DKSH provides Market Expansion Services to DFE Pharma’s starch and disintegrants product range. DFE Pharma expands its collaboration with DKSH for its first-class reputation in providing integrated and tailored Market Expansion Services along the entire value chain, as well as for its comprehensive network and strong customer base in Europe.

“We are very pleased that DFE Pharma has chosen DKSH once again as their Market Expansion Services partner for the distribution of their Pharmacel MCC excipient. Thanks to our unmatched footprint in Europe, we can leverage on our size, experience and industry know-how to provide tailored services and exceptional distribution opportunities for DFE Pharma,” said Tanja Schaffer, Vice President Pharmaceutical Industry, DKSH Performance Materials.

The agreement will further strengthen DKSH’s market position in the regions while contributing to the Group’s overall profitability over time.

About DFE Pharma

DFE Pharma is the global leader in excipient solutions and develops, produces and markets excipients for oral solid dose and dry powder inhalation formulations. DFE Pharma is headquartered in Germany and has production facilities in the Netherlands, Germany, New Zealand and India. DFE Pharma operates in more than 100 countries and has global sales offices in Germany, the United States, Singapore, Japan, India, Brazil and China. DFE Pharma works with a global network with over 100 well-trained agents and distributors.

About DKSH

DKSH is the leading Market Expansion Services provider with a focus on Asia. As the term “Market Expansion Services” suggests, DKSH helps other companies and brands to grow their business in new or existing markets.

Publicly listed on the SIX Swiss Exchange since March 2012, DKSH is a global company headquartered in Zurich. With 750 business locations in 35 countries – 720 of them in Asia – and 27,600 specialized staff, DKSH generated net sales of CHF 9.8 billion in 2014.

In 2015, DKSH celebrates its 150th anniversary. With strong Swiss heritage, the company has a long tradition of doing business in and with Asia, and is deeply rooted in communities and businesses across Asia Pacific.

DKSH Business Unit Performance Materials is a leading specialty chemicals distributor and provider of Market Expansion Services for performance materials, covering Europe, North America and the whole of Asia. The Business Unit sources, develops, markets and distributes a wide range of specialty chemicals and ingredients for pharmaceutical, personal care, food & beverage as well as various industrial applications. In addition, it creates innovative and cutting-edge concepts and applications in 27 innovation centers located worldwide. With 100 business locations in 27 countries and around 950 specialized staff, Business Unit Performance Materials generated net sales of CHF 780 million in 2014.

For further information please contact:

DKSH Management Ltd.

Daniel Hollister

Communications Manager

Business Unit Performance Materials

Phone +44 20 8879 5513

daniel.hollister@dksh.com